Essential role of STAT3 in cytokine-driven NF-κB-mediated serum amyloid A gene expression

Genes to Cells

Volumn 10, Issue 11, 2005, Pages 1051-1063

  Hagihara, Keisuke ^a   Nishikawa, Teppei ^b   Sugamata, Yasuhiro ^b   Song, Jian ^b   Isobe, Tomoyasu ^b   Taga, Tetsuya ^c   Yoshizaki, Kazuyuki ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; PROTEIN P300; SERUM AMYLOID A; STAT3 PROTEIN; SYNAPTOTAGMIN;

3' UNTRANSLATED REGION; AMYLOIDOSIS; ARTICLE; COMPLEX FORMATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

CELLS, CULTURED; CYTOKINES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; RESPONSE ELEMENTS; SERUM AMYLOID A PROTEIN; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 27644549634     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2005.00900.x     Document Type: Article

References (44)

1. Agata, Y., Katakai, T., Ye, S.K., et al. (2001) Histone acetylation determines the developmentally regulated accessibility for T cell receptor gamma gene recombination. J. Exp. Med. 193, 873-880.
2. Akira, S., Nishio, Y., Inoue, M., et al. (1994) Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77, 63-71.
3. Alonzi, T., Maritano, D., Gorgoni, B., et al. (2001) Essential role of STAT3 in the control of acute-phase response as revealed by inducible gene activation in the liver. Mol. Cell. Biol. 21, 1621-1632.
4. Becker, S., Groner, B. & Muller, C.W. (1998) Three-dimensional structure of the Stat3β homodimer bound to DNA. Nature 394, 145-151.
5. Betts, J.C., Cheshire, J.K., Akira, S., Kishimoto, T. & Woo, P. (1993) The role of NF-κB and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J. Biol. Chem. 268, 25624-25631.
6. Bhattacharya, S., Eckner, R., Grossman, S., et al. (1996) Co-operation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 383, 344-347.
7. 2-macroglobulin expression is due to activation of NF-κB. J. Immunol. 167, 1469-1481.
8. Chen, F.E., Huang, D.B., Chen, Y.Q. & Ghosh, G. (1998) Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature 391, 410-413.
9. Feldmann, M., Berman, F.B. & Maini, R.N. (1996) Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14, 397-440.
10. Gillmore, J.D., Laurence, B.L., Persey, M.R., Pepys, M.B. & Hawkins, P.N. (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358, 24-29.
11. Hagihara, K., Nishikawa, T., Isobe, T, et al. (2003) IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem. Biophys. Res. Commun. 314, 363-369.
12. He, R., Sang, H. & Ye, R.D. (2003) Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101, 1572-1581.
13. Horvai, A.E., Xu, L., Korzus, E., et al. (1997) Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl. Acad. Sci. USA 94, 1074-1079.
14. Hough, C., Cuthbert, C.D., Notley, C., et al. (2005) Cell type-specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressor. Blood 105, 1531-1539.
15. Johnson, B.D., Kip, K.E., Marroquin, O.C., et al. (2004) Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women. Circulation 109, 726-732.
16. Kojima, H., Nakajima, K. & Hirano, T. (1996) IL-6-inducible complexes on an IL-6 response element of the junB promoter contain Stat3 and 36 kDa CRE-like site binding protein(s). Oncogene 12, 547-554.
17. Li, Q. & Verma, I.M. (2002) NF-κB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734.
18. Maini, R.N. & Taylor, P.C. (2000) Anti-cytokine therapy for rheumatoid arthritis. Annu. Rev. Med. 51, 207-229.
19. Nakashima, K., Yanagisawa, M., Arakawa, H., et al. (1999) Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 284, 479-482.
20. Niehof, M., Streetz, K., Rakemann, T., et al. (2001) Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPβ promoter suggests a new mechanism of transcriptional regulation by STAT3. J. Biol. Chem. 276, 9016-9027.
21. Nishimoto, N., Sasai, M., Shima, Y., et al. (2000) Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 99, 56-61.
22. Nishimoto, N., Yoshizaki, K., Miyasaka, N., et al. (2004) Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 50, 1761-1769.
23. Paulson, M., Pisharody, S., Pan, L., et al. (1999) Stat protein transactivation domains recruit p300/CBP through widely divergent sequences. J. Biol. Chem. 274, 25343-25349.
24. Ray, A., Hannink, M. & Ray, B.K. (1995) Concerted participation of NF-κB and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver. J. Biol. Chem. 270, 7365-7374.
25. Schaefer, T.S., Sanders, L.K. & Nathans, D. (1995) Cooperative transcriptional activity of Jun and Stat3 β, a short form of Stat3. Proc. Natl. Acad. Sci. USA 92, 9097-9101.
26. Schuringa, J.J., Schepers, H., Vellenga, E. & Kruijer, W. (2001) Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett. 495, 71-76.
27. Seidel, H.M., Milocco, L.H., Lamb, P., et al. (1995) Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. USA 92, 3041-3045.
28. Suzuki, T., Fujisawa, J.I., Toita, M. & Yoshida, M. (1993) The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc. Natl. Acad. Sci. USA 90, 610-614.
29. Thorn, C.F. & Whitehead, A.S. (2002) Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2. J. Immunol. 169, 399-406.
30. Tomita, T., Takeuchi, E., Tomita, N., et al. (1999) Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor κB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum. 42, 2532-2542.
31. Uhlar, C.M. & Whitehead, A.S. (1999) Serum amyloid A, the major vertebrae acute-phase reactant. Eur. J. Biochem. 265, 501-523.
32. Uhlar, C.M., Grehan, S., Steel, D.M., Steinkasserer, A. & Whitehead, A.S. (1997) Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: differential kinetics of SAA2 promoter induction by IL-1 β and TNF-α compared to IL-6. J. Immunol. Methods 203, 123-130.
33. Urieli-Shoval, S., Shubinsky, G., Linke, R.P., et al. (2002) Adhesion of human platelets to serum amyloid A. Blood 95, 1224-1229.
34. Ward, A.C., Hermans, M.H., Smith, L., et al. (1999) Tyrosine-dependent and -independent mechanism of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. Blood 93, 113-124.
35. Wen, Z. & Darnell, J.E. Jr (1997) Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 25, 2062-2067.
36. Wen, Z., Zhong, Z. & Darnell, J.E. Jr (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
37. Yoshida, Y., Kumar, A., Koyama, Y., et al. (2004) Interleukin 1 activates STAT3/nuclear factor-κB cross-talk via a unique TRAF6- and p65-dependent mechanism. J. Biol. Chem. 279, 1768-1776.
38. Youqi, H. & Brasie, A.R. (1997) Mechanism for biphasic rel A. NF-κB1 nuclear translocation in tumor necrosis factor α-stimulated hepatocytes. J. Biol. Chem. 272, 9825-9832.
39. Zhang, Z. & Fuller, G.M. (1997) The competitive binding of STAT3 and NF-κB on an overlapping DNA binding site. Biochem. Biophys. Res. Commun. 237, 90-94.
40. Zhang, Z. & Fuller, G.M. (2000) Interleukin 1β inhibits interleukin 6-mediated rat γ fibrinogen gene expression. Blood 96, 3466.
41. Zhang, D., Sun, M., Samols, D. & Kushner, I. (1996a) STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J. Biol. Chem. 271, 9503-9509.
42. Zhang, J.J., Vinkemeier, U., Gu, W., et al. (1996b) Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc. Natl. Acad. Sci. USA 93, 15092-15096.
43. Zhang, Z., Jones, S., Hagood, J.S., Fuentes, N.L. & Fuller, G.M. (1997) STAT3 acts as a co-activator of glucocorticoid receptor signaling. J. Biol. Chem. 272, 30607-30610.
44. Zhong, H., May, M.J., Jimi, E. & Ghoshi, S. (2002) The phosphorylation status of nuclear NF-κB determines its association with CBP/P300 or HDAC-1. Mol. Cell 9, 625-636.